Keyword: Fred Hutchinson Cancer Research Center
More details on Amazon’s secret skunk-works research division have been revealed, including work in cancer research and EHRs, in reports from CNBC.
The ability to manipulate genes known to play a role in HIV resistance could help eliminate dormant reservoirs of virus that can resurge at any time.
Biotech developments over the past week include promising data from a human trial of male contraception and a new strategy to protect against malaria.
Takeda has added another early-stage research partnership as it reboots its R&D operations, this time teaming with two Seattle-based academic centers.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
Fred Hutchinson scientists have identified biomarkers associated with dangerous side effects possible in cancer patients treated with CAR-T cells.
The agreement gives the Fortress Biotech offshoot a phase 1/2-ready cell therapy to advance alongside its existing clutch of CAR-Ts.
Fred Hutch scientists have created nanoparticles that could address shortcomings associated with CAR-T cancer treatments.
The collaborators hope to learn about the role Sigma1 plays in disease and assess the activity of Context’s inhibitors of the protein.
Juno Therapeutics has halted development of its lead CAR-T therapy months after patient deaths hindered the odds of success.